Clinical commissioning policy: Reimbursement for the use of generic drugs for pre exposure prophylaxis (PrEP) for the prevention of HIV

NHS England will reimburse the use of generic PrEP (tenofovir disoproxil and emtricitabine) for eligible individuals as per the 2018 BHIVA recommendations within approved local authority commissioned PrEP services. Reimbursement for use of Truvada ® is excluded from this policy.

Source:

NHS England